A. Jon Salo < A. Jon Stoessl < A. Jones

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 34.
[0-20] [0 - 20][0 - 34][20-33][20-40]

Ident.	Authors (with country if any)	Title
000074 (2007)	Ronald B. Postuma [Canada] ; Christina Wolfson [Canada] ; Ali Rajput [Canada] ; A. Jon Stoessl [Canada] ; W. R. Wayne Martin [Canada] ; Oksana Suchowersky [Canada] ; Sylvain Chouinard [Canada] ; Michel Panisset [Canada] ; Mandar S. Jog [Royaume-Uni] ; David A. Grimes [Canada] ; Connie Marras [Canada] ; Anthony E. Lang [Canada]	Is there seasonal variation in risk of Parkinson's disease?
000152 (2013)	Pankaj A. Agarwal [Canada] ; A. Jon Stoessl [Canada]	Biomarkers for trials of neuroprotection in Parkinson's disease
000172 (2011)	Raúl De La Fuente-Fernández [Canada] ; Michael Schulzer [Canada] ; Lisa Kuramoto [Canada] ; Jacquelyn Cragg [Canada] ; Nandhagopal Ramachandiran [Canada] ; Wing L. Au [Canada] ; Edwin Mak [Canada] ; Jess Mckenzie [Canada] ; Siobhan Mccormick [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Chong S. Lee [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]	Age‐specific progression of nigrostriatal dysfunction in Parkinson's disease
000207 (2005)	A. Jon Stoessl [Canada] ; Patrick L. Mcgeer [Canada]	Hot spots: Can positron emission tomography offer insights into the pathogenesis of PD?
000254 (2008)	W. R. Wayne Martin ; Marguerite Wieler ; A. Jon Stoessl [Canada] ; Michael Schulzer [Canada]	Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease
000280 (2013)	Silke Appel-Cresswell [Canada] ; Carles Vilarino-Guell [Canada] ; Mary Encarnacion [Canada] ; Holly Sherman [Canada] ; Irene Yu [Canada] ; Brinda Shah [Canada] ; David Weir [Canada] ; Christina Thompson [Canada] ; Chelsea Szu-Tu [Canada] ; Joanne Trinh [Canada] ; Jan O. Aasly [Norvège] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; A. Jon Stoessl [Canada] ; Matthew J. Farrer [Canada]	Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
000350 (2010)	A. Jon Stoessl [Canada]	Continuous dopaminergic therapy in Parkinson disease: Time to stride back?
000418 (2003)	Raúl De La Fuente-Fernández [Canada] ; Andrew S. Lim [Canada] ; Vesna Sossi [Canada] ; Michael J. Adam [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] ; Chong S. Lee [Canada]	Age and severity of nigrostriatal damage at onset of Parkinson's disease
000462 (2007)	Vesna Sossi [Canada] ; Raúl De La Fuente-Fernández [Espagne] ; Michael Schulzer [Canada] ; Andre R. Troiano [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]	Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study
000465 (2011)	A. Jon Stoessl [Canada] ; David J. Brooks [Royaume-Uni] ; David Eidelberg [États-Unis]	Milestones in neuroimaging
000611 (2000)	J. M. Van Kampen [Canada] ; E. G. Mcgeer [Canada] ; A. Jon Stoessl [Canada]	Dopamine transporter function assessed by antisense knockdown in the rat: Protection from dopamine neurotoxicity
000691 (2006)	Anthony E. Lang [Canada] ; Steven Gill [Royaume-Uni] ; Nik K. Patel [Royaume-Uni] ; Andres Lozano [Canada] ; John G. Nutt [États-Unis] ; Richard Penn [États-Unis] ; David J. Brooks [Royaume-Uni] ; Gary Hotton [Royaume-Uni] ; Elena Moro [Canada] ; Peter Heywood [Canada] ; Matthew A. Brodsky [États-Unis] ; Kim Burchiel [États-Unis] ; Patrick Kelly [États-Unis] ; Arif Dalvi [États-Unis] ; Burton Scott [États-Unis] ; Mark Stacy [États-Unis] ; Dennis Turner [États-Unis] ; V. G. Frederich Wooten [États-Unis] ; William J. Elias [États-Unis] ; Edward R. Laws [États-Unis] ; Vijay Dhawan [États-Unis] ; A. Jon Stoessl [Canada] ; James Matcham [Royaume-Uni] ; Robert J. Coffey [États-Unis] ; Michael Traub [États-Unis]	Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease
000704 (2006)	Rodrigo Mercado [Canada] ; Constantine Constantoyannis [Canada] ; Tomasz Mandat [Canada] ; Ajit Kumar [Canada] ; Michael Schulzer [Canada] ; A. Jon Stoessl [Canada] ; Christopher R. Honey [Canada]	Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation
000715 (2001)	Raúl De La Fuente-Fernández [Canada] ; Jian-Qiang Lu [Canada] ; Vesna Sossi [Canada] ; Salma Jivan [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Chong S. Lee [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]	Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover
000738 (1985)	A. Jon Stoessl [Canada] ; E. Mak [Canada] ; Donaldb. Calne [Canada]	(+)-4-PROPYL-9-HYDROXYNAPHTHOXAZINE (PHNO), A NEW DOPAMINOMIMETIC, IN TREATMENT OF PARKINSONISM
000770 (2000)	Raúl De La Fuente-Fernández [Canada] ; Asha Kishore [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]	Nigrostriatal dopamine system and motor lateralization
000867 (2007)	Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada]	Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa
000904 (1998)	Yue Wang [Canada] ; Grace L. Y. Chan [Canada] ; James E. Holden [États-Unis] ; Teresa Dobko [Canada] ; Edwin Mak [Canada] ; Michael Schulzer [Canada] ; Joseph M. Huser [Canada] ; Barry J. Snow [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]	Age‐dependent decline of dopamine D1 receptors in human brain: A PET study
000919 (2010)	André R. Troiano [Canada] ; Michael Schulzer [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Edwin Mak [Canada] ; Jess Mckenzie [Canada] ; Vesna Sossi [Canada] ; Siobhan Mccormick [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]	Dopamine transporter PET in normal aging: Dopamine transporter decline and its possible role in preservation of motor function
000952 (2002)	Pramod K. Pal [Canada] ; Joanne Leung [États-Unis] ; Katya Hedrich [Allemagne] ; Ali Samii [Canada] ; Abraham Lieberman [États-Unis] ; Paul A. Nausieda [États-Unis] ; Donald B. Calne [Canada] ; Xandra O. Breakefield [États-Unis] ; Christine Klein [Allemagne] ; A. Jon Stoessl [Canada]	[18F]‐Dopa positron emission tomography imaging in early‐stage, non‐parkin juvenile parkinsonism
000A53 (2004)	Rau L De La Fuente-Ferna Ndez [Canada] ; Vesna Sossi [Canada] ; Zhigao Huang [Canada] ; Sarah Furtado [Canada] ; Jian-Qiang Lu [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]	Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/Author.i -k "A. Jon Stoessl" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/Author.i  \
                -Sk "A. Jon Stoessl" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    A. Jon Stoessl
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022